查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888994

美国脐血管导管市场规模、份额和趋势分析报告：按产品、材料、通路、适应症/用途、最终用途和细分市场预测（2025-2033 年）

U.S. Umbilical Vessel Catheters Market Size, Share & Trends Analysis Report By Product (Umbilical Arterial Catheters, Umbilical Venous Catheters), By Material, By Channel, By Indication/Use, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10个工作天内

价格

美国脐血管导管市场摘要

2024年美国脐血管导管市场规模估计为1.6539亿美元，预计2033年将达到2.5883亿美元。

预计从 2025 年到 2033 年，该行业将以 5.21% 的复合年增长率成长。这一增长是由早产儿和新生儿併发症的增加所推动的，这些併发症需要即时进行血管通路以进行挽救生命的治疗。

新生儿加护病房(NICU) 基础设施投资的不断增加，以及三级和四级新生儿监护病房的扩建，进一步推动了对该产品的需求。生物相容性材料、防扭结设计以及导管尖端定位精度的提高等技术进步也促进了该产品的应用。此外，临床上对感染预防和安全新生儿血管通路的日益重视，也支持了先进的脐血管导管 (UVC) 和脐动脉导管 (UAC) 系统的持续使用。

早产发生率的上升是推动美国脐血管导管产业成长的主要因素。早产儿在新生儿加护病房(NICU) 中通常需要即时建立可靠的血管通路，以便进行输液、给药和经肠营养。脐血管导管 (UVC 和 UAC) 在维持这些婴儿生命早期关键阶段的生命方面发挥着至关重要的作用。随着全球早产率的上升和存活率的提高，对先进、安全且抗感染导管的需求持续成长。此外，意识提升和新生儿护理基础设施的扩张也进一步推动了全球市场的成长。根据《生殖健康日誌》报道，2020年全球早产儿数量仍居高不下，估计为1,340万人。美国疾病管制与预防中心（CDC）报告称，2020年至2021年，早期和晚期早产的发生率均上升了4%，但2021年至2022年下降了1-2%。

对先进新生儿加护治疗的需求日益增长，是美国脐血管导管产业发展的主要驱动因素。随着早产儿和低出生体重儿数量的持续增加，对可靠、安全的血管通路解决方案的需求也显着增加。脐血管导管在输送必需药物、液体和营养方面发挥至关重要的作用，同时也能对严重新生儿进行持续监测。新生儿加护病房（NICU）的扩建和先进医疗技术的应用进一步推动了其使用。此外，提高新生儿存活率和减少併发症的日益重视，也加速了全球医院对高性能、抗感染导管的采用。

三级和四级新生儿加护病房的扩建也推动了美国脐血管导管产业的成长。这些先进的医疗机构收治了大量需要紧急血管通路的早产儿和严重新生儿。随着越来越多的医院提升新生儿加护病房（NICU）的水平，对可靠的脐血管导管（UVC）和脐动脉导管（UAC）的需求日益增长，以支持诸如液体復苏、经肠营养、药物输注和持续监测等救生操作。这些机构严格遵循临床通讯协定，并规范脐导管的使用，以确保其使用一致性。随着对专业新生儿护理基础设施投资的不断增加，高品质导管对于提供先进的新生儿护理变得愈发重要。

目录

第一章调查方法和范围

第二章执行摘要

第三章美国脐血管导管市场变数、趋势与范围

  • 市场谱系展望
    • 相关市场展望
  • 市场动态
  • 美国脐血管导管市场分析工具
    • 波特分析
    • PESTEL 分析

第四章美国脐血管导管市场：按产品分類的估算与趋势分析

  • 美国脐血管导管市场产品变化分析
  • 美国脐血管导管市场规模及趋势分析（依产品分类，2021-2033 年）
  • 脐动脉导管（UAC）
  • 脐静脉导管（UVC）

第五章美国脐血管导管市场：依材料分類的估算与趋势分析

  • 美国脐血管导管市场材料差异分析
  • 美国脐血管导管市场规模及趋势分析（依材料划分，2021-2033 年）
  • 聚氨酯导管
  • 硅胶导管
  • PVC涂层导管
  • 其他的

第六章：美国脐血管导管市场：按通路的估算和趋势分析

  • 依分销管道分析美国脐血管导管市场通路
  • 美国脐血管导管市场规模及趋势分析（依通路划分）（2021-2033 年）
  • 单腔
  • 双腔
  • 三流明

第七章 脐血管导管市场：依适应症/应用分類的估算与趋势分析

  • 美国脐血管导管市场：按适应症/应用分類的差异分析
  • 美国脐血管导管市场规模及趋势分析（依适应症/应用划分，2021-2033 年）
  • 新生儿静脉通路困难（DVA）的紧急復苏
  • 换血疗法
  • 心臟导管插入术
  • 肠外营养
  • 药物管理
  • 频繁的血液采样/动脉血气监测

第八章美国脐血管导管市场：按最终用途分類的估算和趋势分析

  • 美国脐血管导管市场按最终用途分類的差异分析
  • 美国脐血管导管市场规模及趋势分析（依最终用途划分，2021-2033年）
  • 医院（新生儿加护病房）
  • 专科诊所或中心
  • 门诊手术中心

第九章 竞争情势

  • 市场参与企业分类
  • 主要企业简介
    • Vygon
    • Utah Medical Products, Inc.
    • Cardinal Health
    • Laborie
    • AMECATH
    • Neotech Products
  • 2024年企业市场占有率分析
  • 其他主要市场公司名单
Product Code: GVR-4-68040-822-9

U.S. Umbilical Vessel Catheters Market Summary

The U.S. umbilical vessel catheters market size was estimated at USD 165.39 million in 2024 and is projected to reach USD 258.83 million by 2033, growing at a CAGR of 5.21% from 2025 to 2033. This growth is attributed to the rising prevalence of preterm births and neonatal complications that require immediate vascular access for life-saving interventions.

Growing investments in NICU infrastructure, coupled with the expansion of Level III and Level IV neonatal care units, further strengthen demand for the product. Technological improvements, such as biocompatible materials, kink-resistant designs, and enhanced catheter tip positioning, also enhance adoption. Furthermore, heightened clinical emphasis on infection prevention and safe neonatal vascular access supports the continued use of advanced UVC and UAC systems.

The rising incidence of preterm births is a primary factor driving the growth of the U.S. umbilical vessel catheters industry. Preterm infants often require immediate and reliable vascular access for administering fluids, medications, and parenteral nutrition in neonatal intensive care units (NICUs). Umbilical vessel catheters (UVCs and UACs) play a crucial role in stabilizing these infants during the critical early stages of life. With increasing global preterm birth rates and improved survival outcomes, the demand for advanced, safe, and infection-resistant catheters continues to rise. Moreover, growing awareness among healthcare professionals and the expansion of neonatal care infrastructure further support market growth worldwide. According to the Reproductive Health Journal, the number of preterm births remained high globally, with an estimated 13.4 million cases in 2020. According to the Centers for Disease Control and Prevention (CDC), both early and late preterm birth rates increased by 4% from 2020 to 2021 but later declined by 1%-2% from 2021 to 2022.

The growing need for advanced neonatal intensive care is a major factor driving the U.S. umbilical vessel catheters industry. As the number of preterm and low-birth-weight infants continues to rise, the demand for reliable and safe vascular access solutions has increased significantly. Umbilical vessel catheters play a crucial role in delivering essential medications, fluids, and nutrition while allowing continuous monitoring of critically ill newborns. The expansion of neonatal intensive care units (NICUs) and the adoption of advanced medical technologies are further enhancing their use. In addition, the focus on improving neonatal survival rates and reducing complications is accelerating the adoption of high-performance, infection-resistant catheters across hospitals worldwide.

The expansion of Level III and Level IV neonatal care units is another driver of the U.S. umbilical vessel catheter industry, as these advanced facilities manage the highest volume of premature and critically ill newborns requiring immediate vascular access. As more hospitals upgrade their NICU capabilities, the demand for reliable UVCs and UACs increases to support life-saving interventions, including fluid resuscitation, parenteral nutrition, medication delivery, and continuous monitoring. These units follow stringent clinical protocols that standardize the use of umbilical catheters, ensuring consistent utilization. As investment in specialized neonatal infrastructure increases, the need for high-quality catheters becomes even more crucial in delivering advanced newborn care.

U.S. Umbilical Vessel Catheters Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. umbilical vessel catheters market report based on product, material, channel, indication/use and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Umbilical Arterial Catheters (UACs)
  • Umbilical Venous Catheters (UVCs)
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Polyurethane-based Catheters
  • Silicone-based Catheters
  • PVC-coated Catheters
  • Others
  • Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Single Lumen
  • Double Lumen
  • Triple Lumen
  • Indication/Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation
  • Exchange Blood Transfusion
  • Cardiac Catheterisation
  • Parenteral Nutrition
  • Drug Administration
  • Frequent Blood Sampling/Arterial Blood Gas Monitoring
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals (NICUs)
  • Specialty Clinics or Centers
  • Ambulatory Surgery Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Material
    • 1.2.3. Channel
    • 1.2.4. Indication/Use
    • 1.2.5. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
    • 1.5.5. Information Analysis
  • 1.6. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Umbilical Vessel Catheters Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising preterm births and neonatal complications
      • 3.2.1.2. Expansion of level III and level IV NICUs
      • 3.2.1.3. Growing focus on neonatal survival and early intervention
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of catheter-related complications
      • 3.2.2.2. Strict regulatory requirements
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Growing NICU infrastructure investments
      • 3.2.3.2. Technological advancements
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Maintaining high safety standards
      • 3.2.4.2. Short window of use
  • 3.3. U.S. Umbilical Vessel Catheters Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Umbilical Vessel Catheters Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Umbilical Vessel Catheters Market Product Movement Analysis
  • 4.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Umbilical Arterial Catheters (UACs)
    • 4.4.1. Umbilical Arterial Catheters (UACs) U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Umbilical Venous Catheters (UVCs)
    • 4.5.1. Umbilical Venous Catheters (UVCs) U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Umbilical Vessel Catheters Market: Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Umbilical Vessel Catheters Market Material Movement Analysis
  • 5.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
  • 5.4. Polyurethane-based Catheters
    • 5.4.1. Polyurethane-based Catheters U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Silicone-based Catheters
    • 5.5.1. Silicone-based Catheters U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. PVC-coated Catheters
    • 5.6.1. PVC-coated Catheters U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Umbilical Vessel Catheters Market: Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Umbilical Vessel Catheters Market Channel Movement Analysis
  • 6.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Channel, 2021 to 2033 (USD Million)
  • 6.4. Single Lumen
    • 6.4.1. Single Lumen U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Double Lumen
    • 6.5.1. Double Lumen U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Triple Lumen
    • 6.6.1. Triple Lumen U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Umbilical Vessel Catheters Market: Indication/Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Umbilical Vessel Catheters Market Indication/Use Movement Analysis
  • 7.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Indication/Use, 2021 to 2033 (USD Million)
  • 7.4. Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation
    • 7.4.1. Neonates with difficult venous access (DVA) for emergency resuscitation market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.5. Exchange Blood Transfusion
    • 7.5.1. Exchange blood transfusion market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.6. Cardiac Catheterisation
    • 7.6.1. Cardiac catheterisation market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.7. Parenteral Nutrition
    • 7.7.1. Parenteral nutrition market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.8. Drug Administration
    • 7.8.1. Drug administration market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.9. Frequent blood sampling/arterial blood gas monitoring
    • 7.9.1. Frequent blood sampling/arterial blood gas monitoring market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. U.S. Umbilical Vessel Catheters Market: End-Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Umbilical Vessel Catheters Market End-Use Movement Analysis
  • 8.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
  • 8.4. Hospitals (NICUs)
    • 8.4.1. Hospitals (NICUs) U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Specialty Clinics or Centers
    • 8.5.1. Specialty Clinics or Centers U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Ambulatory Surgery Centers
    • 8.6.1. Ambulatory Surgery Centers U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Vygon
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Material Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Utah Medical Products, Inc.
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Material Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Cardinal Health
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Material Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Laborie
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Material Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. AMECATH
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Material Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. Neotech Products
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Material Benchmarking
      • 9.2.6.4. Strategic Initiatives
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. List of Other Key Market Players

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Umbilical Vessel Catheters Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 U.S. Umbilical Vessel Catheters Market, by Material, 2021 - 2033 (USD Million)
  • Table 5 U.S. Umbilical Vessel Catheters Market, by Channel, 2021 - 2033 (USD Million)
  • Table 6 U.S. Umbilical Vessel Catheters Market, by Indications/Use, 2021 - 2033 (USD Million)
  • Table 7 U.S. Umbilical Vessel Catheters Market, by End-Use, 2021 - 2033 (USD Million)
  • Table 8 Participant's Overview
  • Table 9 Financial Performance
  • Table 10 Material Benchmarking
  • Table 11 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Umbilical Vessel Catheters Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Regional Marketplace: Key Takeaways
  • Fig. 13 U.S. Umbilical Vessel Catheters Market, for Product, 2021 - 2033 (USD Million)
  • Fig. 14 U.S. Umbilical Vessel Catheters Market, for Umbilical Arterial Catheters (UACs), 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Umbilical Vessel Catheters Market, for Umbilical Venous Catheters (UVCs), 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Umbilical Vessel Catheters Market, for Material, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Umbilical Vessel Catheters Market, for Polyurethane-based Catheters, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Umbilical Vessel Catheters Market, for Silicone-based Catheters, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Umbilical Vessel Catheters Market, for PVC-coated Catheters, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Umbilical Vessel Catheters Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Umbilical Vessel Catheters Market, for Channel, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Umbilical Vessel Catheters Market, for Single Lumen, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Umbilical Vessel Catheters Market, for Double Lumen, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Umbilical Vessel Catheters Market, for Triple Lumen, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Umbilical Vessel Catheters Market, for Indication/Use, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Umbilical Vessel Catheters Market, for Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Umbilical Vessel Catheters Market, for Exchange Blood Transfusion, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Umbilical Vessel Catheters Market, for Cardiac Catheterisation, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Umbilical Vessel Catheters Market, for Drug Administration, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Umbilical Vessel Catheters Market, for Frequent Blood Sampling/Arterial Blood Gas Monitoring, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Umbilical Vessel Catheters Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Umbilical Vessel Catheters Market, for Hospitals (NICUs), 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Umbilical Vessel Catheters Market, for Specialty Clinics or Centers, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Umbilical Vessel Catheters Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)